Press-release for stocks in the health technology sector

Prices are updated after-hours

for sector : Health technology

save search

Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024
Published: 2024-04-19 (Crawled : 15:00) - globenewswire.com
ZEAL | News | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
pharma management for

Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19 (Crawled : 15:00) - biospace.com/
PRGO | News | $30.8 2.87% -1.14% 1.2M

Health Technology

| 0.0% | O: -0.13% H: 0.0% C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| 0.0% | O: 0.79% H: 0.0% C: 0.0%
ABT | News | $107.28 1.91% 0.18% 10M

Health Technology

| 0.0% | O: -0.75% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

Health Technology

| 0.0% | O: 0.82% H: 0.0% C: 0.0%
first treatment for

Health Canada Approves KEYTRUDA as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma
Published: 2024-04-19 (Crawled : 13:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M

Health Technology

| 0.0% | O: 0.5% H: 0.0% C: 0.0%
health treatment for canada advanced keytruda

FDA Requires Boxed Warning for Secondary Cancers on CAR-T Therapies
Published: 2024-04-19 (Crawled : 12:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| 0.0% | O: 0.79% H: 0.0% C: 0.0%
fda for car-t

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)
Published: 2024-04-19 (Crawled : 10:00) - globenewswire.com
ALVO | News | $13.23 2.64% 2.57% 1.7M

n/a

| -1.32% | O: 4.19% H: 0.0% C: 0.0%
KMDA | News | $5.05 -0.98% -0.99% 27K

Health Technology

| -0.1% | O: 1.76% H: 0.0% C: 0.0%
humira biosimilar approved for agreement

Class Action Filed Against iRobot Corporation (IRBT) Seeking Recovery for Investors - Contact The Gross Law Firm
Published: 2024-04-19 (Crawled : 10:00) - prnewswire.com
EVLV | News | $3.835 -2.67% -2.74% 920K

| 3.82% | O: 3.43% H: 0.0% C: 0.0%
IRBT | News | $7.23 -0.28% -0.28% 1.5M

Consumer Durables

| 0.14% | O: 7.19% H: 0.0% C: 0.0%
IESC | News | $115.44 -0.37% -0.37% 120K

Industrial Services

| -1.25% | O: -1.33% H: 0.0% C: 0.0%
AVXL | News | $3.8 0.0% 2.1M

Health Technology

| -6.63% | O: -8.11% H: 0.0% C: 0.0%
corporation for

U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Published: 2024-04-18 (Crawled : 23:00) - biospace.com/
TAK | News | $13.24 0.61% 0.0% 1.3M

Health Technology

| 0.0% | O: 0.0% H: 0.0% C: 0.0%
entyvio fda disease active for therapy

Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering
Published: 2024-04-18 (Crawled : 21:00) - globenewswire.com
HSTO | $0.5 67.46% 530

Health Technology

| Email alert Add to watchlist
offering for

Lumos Pharma Announces Abstracts Accepted for Presentation at Upcoming Medical Meetings
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
LUMO | $2.57 -1.91% -1.95% 12K

Health Technology

| Email alert Add to watchlist
pharma presentation for medical

European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
MBRX | $4.65 2.8% 2.72% 11K

Health Technology

| 5.61% | O: 4.91% H: 11.36% C: 0.67%
drug treatment designation for grants leukemia

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024Conference call scheduled for 4:30 p.m. Eastern Time
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ARDX | $6.5 0.93% 0.92% 5.6M

Health Technology

| -4.31% | O: -2.97% H: 0.61% C: -1.38%
first report for financial results

Form Bio Establishes Scientific Advisory Board, Comprised of Renowned Experts in Cell and Gene Therapy, for Advancing AI-Driven Therapies
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
FDMT M | $25.29 2.06% 2.02% 630K

Health Technology

| -1.23% | O: -1.23% H: 0.0% C: 0.0%
cell for

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.
Published: 2024-04-18 (Crawled : 14:00) - globenewswire.com
GRFS | News | $6.29 -3.82% -3.97% 1.2M

Health Technology

| -0.61% | O: 0.91% H: 0.0% C: -1.51%
for

Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M

Health Technology

| 0.12% | O: 0.12% H: 0.0% C: 0.0%
fda biosimilar approval for stelara

Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer
Published: 2024-04-18 (Crawled : 13:00) - globenewswire.com
ONCT | $8.97 4.3% 4.12% 4.5K

Health Technology

| Email alert Add to watchlist
onct-534 first cancer treatment for study

World IBS Day - April 19th: Raising Awareness for Everyone with IBS
Published: 2024-04-18 (Crawled : 13:00) - prnewswire.com
ARDX | $6.5 0.93% 0.92% 5.6M

Health Technology